| __timestamp | Halozyme Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 11503000 |
| Thursday, January 1, 2015 | 105812000 | 24698000 |
| Friday, January 1, 2016 | 113485000 | 26076000 |
| Sunday, January 1, 2017 | 285461000 | 33570000 |
| Monday, January 1, 2018 | 141726000 | 58697000 |
| Tuesday, January 1, 2019 | 150446000 | 80279000 |
| Wednesday, January 1, 2020 | 224227000 | 84228000 |
| Friday, January 1, 2021 | 361897000 | 106025000 |
| Saturday, January 1, 2022 | 520812000 | 109788000 |
| Sunday, January 1, 2023 | 636892000 | 135576000 |
| Monday, January 1, 2024 | 855907000 |
Unleashing insights
In the competitive landscape of biotechnology, Halozyme Therapeutics, Inc. and Vericel Corporation have showcased remarkable growth in gross profit over the past decade. Since 2014, Halozyme has consistently outperformed Vericel, with its gross profit surging by over 1,100% by 2023. This impressive growth trajectory highlights Halozyme's strategic advancements and market adaptability.
Vericel, while trailing behind, has also demonstrated significant progress, with its gross profit increasing by nearly 1,080% during the same period. This growth reflects Vericel's commitment to innovation and its expanding footprint in the regenerative medicine sector.
The data reveals a compelling narrative of two companies navigating the dynamic biotech industry, with Halozyme leading the charge. As we look to the future, these trends underscore the importance of strategic investments and innovation in driving financial success.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Vericel Corporation
Key Insights on Gross Profit: GSK plc vs Vericel Corporation
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Dr. Reddy's Laboratories Limited and Vericel Corporation
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Ascendis Pharma A/S vs Vericel Corporation
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.